Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4464429
Max Phase: Preclinical
Molecular Formula: C51H80N2O16
Molecular Weight: 977.20
Molecule Type: Unknown
Associated Items:
ID: ALA4464429
Max Phase: Preclinical
Molecular Formula: C51H80N2O16
Molecular Weight: 977.20
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CC(OC(=O)c2ccccc2)C(=O)NC(C)(C)C)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@H]1O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]1OC
Standard InChI: InChI=1S/C51H80N2O16/c1-14-37-34(26-64-50-46(63-13)45(62-12)42(58)31(6)66-50)22-27(2)20-21-35(54)28(3)23-33(24-38(47(60)52-51(7,8)9)68-48(61)32-18-16-15-17-19-32)44(29(4)36(55)25-39(56)67-37)69-49-43(59)40(53(10)11)41(57)30(5)65-49/h15-22,28-31,33-34,36-38,40-46,49-50,55,57-59H,14,23-26H2,1-13H3,(H,52,60)/b21-20+,27-22+/t28-,29+,30-,31+,33-,34-,36-,37-,38?,40+,41-,42+,43-,44-,45+,46+,49+,50+/m1/s1
Standard InChI Key: OJDMBUZIZPESJX-PROCVPGJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 977.20 | Molecular Weight (Monoisotopic): 976.5508 | AlogP: 3.50 | #Rotatable Bonds: 14 |
Polar Surface Area: 238.31 | Molecular Species: NEUTRAL | HBA: 17 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: 7.94 | CX LogP: 4.56 | CX LogD: 3.91 |
Aromatic Rings: 1 | Heavy Atoms: 69 | QED Weighted: 0.17 | Np Likeness Score: 1.18 |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):